1-6 of 6
Deirdre O'Mahony, MD
Close
Sort by
Journal Articles

Procarbazine-Free Escalated Beacopdac in Frontline Therapy of Advanced Hodgkin Lymphoma Reduces Red Cell Transfusion Requirements and May Shorten Time to Menstrual Period Recovery Compared to Escalated Beacopp and Appears to be As Efficacious

Anna Santarsieri, MBBS, Katherine Sturgess, MA, MBBChir, MRCP, MSc, Pauline Brice, Tobias F Menne, MD PhD FRCPath, Wendy Osborne, MD, Thomas Creasey, MBBS, Kirit M. Ardeshna, MA, MD FRCP, FRCPath, Sarah Behan, Stephen Booth, MA,MBBChir,MRCP,FRCPath, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Kate Cwynarski, PhDMD, Sunil Iyengar, MD, Stephen G Jones, Deirdre O'Mahony, MD, Nicolas Martinez-Calle, MD MSc, Pamela McKay, MD, Sateesh K Nagumantry, BM BCh, John Rudge, MA, PhD, Nimish Shah, MD, Gwyneth Stafford, Alexander Sternberg, Benjamin J Uttenthal, MD PhD, Andrew K McMillan, FRCP, George A Follows, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1564.
https://doi.org/10.1182/blood-2019-125256
Published: 2019
Journal Articles

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Kamal Sharma, DO, John E. Janik, MD, Deirdre O’Mahony, MD, Donn Stewart, MD, Stefania Pittaluga, MD, Maryalice Stetler-Stevenson, MD, PhD, Elaine S. Jaffe, MD, Mark Raffeld, MD, Thomas A. Fleisher, MD, Cathryn C. Lee, NP, Nicole Urquhart, MD, Seth Steinberg, PhD, Thomas A. Waldmann, MD, John C. Morris, MD
Journal: Blood
Blood (2008) 112 (11): 2010.
https://doi.org/10.1182/blood.V112.11.2010.2010
Published: 2008
Journal Articles

Yttrium-90 Radiolabeled Humanized Monoclonal Antibody to CD25 in Refractory and Relapsed Hodgkin’s Lymphoma

Deirdre O’Mahony, MD, John E Janik, MD, Jorge A. Carrasquillo, MD, Pamela Seam, MD, Joseph A Fiorillo, MD, Donn Stewart, MD, Chang H Paik, PhD, Suzanne Fioravanti, RN, Millie Whatley, RNMT, Stefania Pittaluga, MD, PhD, Martin W Brechbiel, PhD, John C Morris, MD, Thomas A Waldmann, MD
Journal: Blood
Blood (2008) 112 (11): 231.
https://doi.org/10.1182/blood.V112.11.231.231
Published: 2008
Journal Articles

Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD).

Deirdre O’Mahony, MD, Wendy Bernstein, MD, Kathy Wyvill, RN, Karen Aleman, RN, Denise Whitby, PhD, Seth Steinberg, PhD, Giovanna Tosato, MD, Stefania Pittaluga, MD, Elaine S. Jaffe, MD, Robert Yarchoan, MD, Richard F. Little, MD
Journal: Blood
Blood (2007) 110 (11): 514.
https://doi.org/10.1182/blood.V110.11.514.514
Published: 2007
Journal Articles

EBV-Related Lymphoproliferative Disease Complicating Therapy with Siplizumab, a Novel Anti-CD2 Mediated T- and NK-Cell Depleting Agent, in Patients with T-Cell Malignancies.

Deirdre O’Mahony, MD, John C. Morris, MD, Maryalice Stetler-Stevenson, MD, Helen Matthews, RN, Stefania Pittaluga, MD, Paul Albert, PhD, Karen Kaucic, MD, Luz Hammershaimb, MD, Thomas A. Waldmann, MD, John E. Janik, MD
Journal: Blood
Blood (2007) 110 (11): 3565.
https://doi.org/10.1182/blood.V110.11.3565.3565
Published: 2007
Journal Articles

Phase I Trial of Siplizumab in CD2-Positive Lymphoproliferative Disease.

Deirdre O’Mahony, MD, John C. Morris, MD, Leslie Moses, Diana O’Hagan, Wendy Gao, Maryalice Stetler-Stevenson, MD, Margaret Taylor, Luz Hammershaimb, MD, Thomas A. Waldmann, John E. Janik, MD
Journal: Blood
Blood (2005) 106 (11): 3353.
https://doi.org/10.1182/blood.V106.11.3353.3353
Published: 2005